- Investing Ideas
- /
- Swedish Fast Growing Stocks With High Insider Ownership
Swedish Fast Growing Stocks With High Insider Ownership
Results
90
0 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
90 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.19 | -2.1% | 0.3% | SEK 323.2m | SEK 2.20 | PS2.8x | E86.1% | n/a | Tech | ||
YUBICO | SEK 216.50 | -15.9% | 113.5% | SEK 18.6b | SEK 321.67 | PE96.2x | E42.3% | n/a | Software | ||
MAGLE | SEK 38.20 | 1.6% | 20.1% | SEK 412.6m | SEK 50.00 | PE53.6x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 270.00 | -1.5% | 22.2% | SEK 3.4b | n/a | PE33.2x | E24.8% | 2.0% | Capital Goods | ||
TRUE B | SEK 37.70 | 4.7% | 3.0% | SEK 13.0b | SEK 57.20 | PE27.2x | E21.6% | 1.1% | Software | ||
FNOX | SEK 63.10 | 5.3% | 8.0% | SEK 38.5b | SEK 77.88 | PE59.2x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 169.40 | -2.6% | -42.8% | SEK 15.0b | SEK 290.60 | PS50x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.85 | 7.4% | -57.4% | SEK 239.2m | SEK 6.20 | PS32.3x | E78.5% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.24 | -5.9% | -6.3% | SEK 242.3m | SEK 2.84 | PS2.2x | E115.5% | n/a | Tech | ||
CRAD B | SEK 40.55 | -0.7% | 30.8% | SEK 1.4b | SEK 57.00 | PE25.4x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.01 | -1.3% | -17.5% | SEK 295.3m | SEK 3.00 | PS2.1x | E109.0% | n/a | Materials | ||
AWRD | SEK 124.00 | -3.9% | 50.3% | SEK 1.1b | SEK 140.00 | PE44.4x | E34.2% | 1.9% | Media | ||
FLEXQ | SEK 9.06 | -9.2% | -44.4% | SEK 121.4m | SEK 25.00 | PS1.1x | E118.7% | n/a | Capital Goods | ||
CTM | SEK 7.15 | -3.0% | -63.6% | SEK 540.9m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
4C | SEK 16.05 | 3.5% | -32.0% | SEK 563.9m | SEK 22.00 | PS1.9x | E108.0% | n/a | Software | ||
KLAR | SEK 0.73 | 38.5% | 16.9% | SEK 95.2m | SEK 1.00 | PB4.6x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 353.90 | 9.2% | 72.9% | SEK 418.1b | SEK 355.17 | PE122.5x | E35.6% | 1.0% | Diversified Financials | ||
SENZA | SEK 7.45 | 1.4% | -9.1% | SEK 219.8m | SEK 16.00 | PS4x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
EGTX | SEK 4.91 | -12.5% | 15.8% | SEK 1.4b | SEK 11.40 | PS20.3x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
RUSTA | SEK 74.35 | 10.0% | n/a | SEK 11.3b | SEK 86.00 | PE25x | E21.5% | 1.5% | Retail | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.45 | -4.7% | -55.4% | SEK 167.2m | n/a | PS1.8x | E66.8% | n/a | Software | ||
RAIL | SEK 31.50 | 2.9% | 73.1% | SEK 759.9m | SEK 34.00 | PE17.3x | E27.0% | 2.2% | Transportation | ||
LIME | SEK 325.00 | 2.8% | 27.0% | SEK 4.3b | SEK 366.25 | PE50.2x | E22.7% | 1.1% | Software |